Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_assertion type Assertion NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_head.
- NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_assertion description "[We have recently shown that a novel, reversible MetAP2 inhibitor, A-357300, significantly inhibits CHP-134-derived neuroblastoma s.c. xenograft growth rate with a treatment-to-control (T/C) ratio at day 24 of 0.19 (P < 0.001) without toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_provenance.
- NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_assertion evidence source_evidence_literature NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_provenance.
- NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_assertion SIO_000772 15814649 NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_provenance.
- NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_assertion wasDerivedFrom befree-2016 NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_provenance.
- NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_assertion wasGeneratedBy ECO_0000203 NP488824.RAijvK8ePTzQWXC482N_nqVpqaz2N9s4vZODCJVc25Wgk130_provenance.